{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:45:20Z","timestamp":1792079120311,"version":"4.4.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-coi260045-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Meningioma incidence is rising globally, yet many tumors follow an indolent course. Despite low intervention rates, surveillance imaging is extensive, and it is unclear whether current practices meaningfully influence treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi260045-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify nationwide Danish trends in meningioma incidence, treatment, and surveillance and identify potentially redundant follow-up imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi260045-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This nationwide quality improvement study integrated data from the Danish National Patient Registry and Danish Pathology Registry. All adults diagnosed with meningioma based on radiologic or histopathologic findings in Denmark between January 1, 2010, and December 31, 2023, were included. Follow-up extended through December 31, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi260045-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Meningioma diagnosis and neuroimaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi260045-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcomes were trends in meningioma incidence from 2010 through 2023, treatment conversion rates (surgery or radiotherapy), and surveillance imaging volume. Secondary outcomes included intervention timing and imaging use after final treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi260045-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 8134 patients with meningioma were included (median age, 66 years [range, 18-102 years]; 6002 [73.7%] women). The age- and sex-standardized incidence rate increased from 6.4 (95% CI, 5.0-7.8) to 12.6 (95% CI, 10.8-14.5) per 100\u202f000 person-years between 2010 and 2023, yet yearly treatment rates remained stable. A total of 5307 patients (65.2%) received no treatment, while 2665 (32.8%) underwent surgery and 439 (5.4%) received radiotherapy. Histopathologic examination confirmed World Health Organization grade 1 tumors in 2379 patients who underwent surgery (89.3%). Surveillance imaging was common, with 7143 patients (87.8%) receiving 1 or more follow-up magnetic resonance imaging (MRI) scan. Of 28\u202f736 MRI scans, 23\u202f992 (83.5%) were not followed by treatment. Imaging beyond 5 years after diagnosis rarely led to changes in treatment but accounted for a substantial proportion of total scans. Only 78 of 5547 patients (1.4%) underwent surgery after year 5.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi260045-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this quality improvement study, meningioma incidence increased substantially between 2010 and 2023, while treatment rates remained stable. Most imaging did not result in intervention, suggesting that a substantial proportion of follow-up imaging could be reduced within a risk-adapted framework.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoncol.2026.2943","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:46Z","timestamp":1787238046000},"page":"1107","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Meningioma Incidence, Treatment, and Imaging Surveillance"],"prefix":"10.1001","volume":"12","author":[{"given":"Anders Rosendal","family":"Korsh\u00f8j","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Engberg","sequence":"additional","affiliation":[{"name":"The Danish Healthcare Quality Institute, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Haldrup","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kudsk","family":"Ragner","sequence":"additional","affiliation":[{"name":"The Danish Healthcare Quality Institute, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Lind","family":"Olsen","sequence":"additional","affiliation":[{"name":"The Danish Healthcare Quality Institute, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuozima","family":"Azam","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiit Illimar","family":"Mathiesen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rigshospitalet, K\u00f8benhavn, Denmark"},{"name":"Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Albarazi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scheie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rigshospitalet, K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavka","family":"Lukacova","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Oncology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e5re Schmidt","family":"Ettrup","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Aalborg University Hospital, Gistrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Bonde","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Skj\u00f8th-Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rigshospitalet, K\u00f8benhavn, Denmark"},{"name":"Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinbj\u00f8rn","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Southern Denmark, Odense, Denmark"},{"name":"Department of Oncology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"coi260045r1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2018-2022.","volume":"27","author":"Price","year":"2025","journal-title":"Neuro Oncol"},{"issue":"1","key":"coi260045r2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00401-023-02571-3","article-title":"Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.","volume":"146","author":"Wang","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"2","key":"coi260045r3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","article-title":"cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro Oncol"},{"issue":"5","key":"coi260045r4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","article-title":"A molecularly integrated grade for meningioma.","volume":"24","author":"Driver","year":"2022","journal-title":"Neuro Oncol"},{"issue":"4","key":"coi260045r5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737140.2023.2193333","article-title":"Overview and recent advances in incidental meningioma.","volume":"23","author":"N\u00e4slund","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"coi260045r6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/noab132","article-title":"An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study.","volume":"24","author":"Sheehan","year":"2022","journal-title":"Neuro Oncol"},{"issue":"11","key":"coi260045r7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas.","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"issue":"2","key":"coi260045r8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11060-023-04482-5","article-title":"Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?","volume":"165","author":"N\u00e4slund","year":"2023","journal-title":"J Neurooncol"},{"issue":"1","key":"coi260045r9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamaoncol.2025.4821","article-title":"A clinical tool to identify incidental meningioma for early outpatient management.","volume":"12","author":"Islim","year":"2026","journal-title":"JAMA Oncol"},{"key":"coi260045r10","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noag086","article-title":"Incidental meningiomas have favorable clinical outcomes across molecular classification systems.","author":"Nguyen","year":"2026","journal-title":"Neuro Oncol"},{"key":"coi260045r11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2147\/CLEP.S99459","article-title":"The Danish Neuro-Oncology Registry.","volume":"8","author":"Hansen","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"1","key":"coi260045r12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s13104-016-2233-x","article-title":"The Danish Neuro-Oncology Registry: establishment, completeness and validity.","volume":"9","author":"Hansen","year":"2016","journal-title":"BMC Res Notes"},{"key":"coi260045r13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions.","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"},{"issue":"8","key":"coi260045r14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology.","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"coi260045r15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7","key":"coi260045r16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register.","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"coi260045r17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"8","key":"coi260045r18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"9596","key":"coi260045r20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"7624","key":"coi260045r21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"12","key":"coi260045r22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"issue":"5","key":"coi260045r23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"coi260045r24","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015.","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"issue":"6","key":"coi260045r25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ijc.21255","article-title":"Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997.","volume":"117","author":"Klaeboe","year":"2005","journal-title":"Int J Cancer"},{"issue":"1","key":"coi260045r26","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae007","article-title":"Long-term health-related quality of life in meningioma survivors: a mixed-methods systematic review.","volume":"6","author":"Frances","year":"2024","journal-title":"Neurooncol Adv"},{"issue":"3","key":"coi260045r27","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13132","article-title":"Clinical implementation of integrated molecular-morphologic risk prediction for meningioma.","volume":"33","author":"Hielscher","year":"2023","journal-title":"Brain Pathol"},{"issue":"34","key":"coi260045r28","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated.","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"coi260045r29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/neuonc\/noae253","article-title":"European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection.","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro Oncol"},{"issue":"11","key":"coi260045r30","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1093\/brain\/awaa267","article-title":"PET imaging of meningioma with 18F-FLT: a predictor of tumour progression.","volume":"143","author":"Bashir","year":"2020","journal-title":"Brain"},{"issue":"19","key":"coi260045r31","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1001\/jama.2018.2202","article-title":"Choosing Wisely campaigns: a work in progress.","volume":"319","author":"Levinson","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"coi260045r32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bmjqs-2014-003821","article-title":"\u2018Choosing Wisely\u2019: a growing international campaign.","volume":"24","author":"Levinson","year":"2015","journal-title":"BMJ Qual Saf"},{"issue":"10","key":"coi260045r33","article-title":"The Danish Choosing Wisely concept.","volume":"68","author":"Malling","year":"2021","journal-title":"Dan Med J"},{"issue":"3","key":"coi260045r35","first-page":"478","article-title":"An evidence-based framework for postoperative surveillance of meningioma.","volume":"12","author":"Owusu-Adjei","year":"2024","journal-title":"Neurooncol Pract"},{"issue":"6","key":"coi260045r36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.wneu.2011.05.015","article-title":"Long-term 25-year follow-up of surgically treated parasagittal meningiomas.","volume":"76","author":"Pettersson-Segerlind","year":"2011","journal-title":"World Neurosurg"},{"key":"coi260045r37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737520","article-title":"A novel MRI-based risk stratification algorithm for predicting postoperative recurrence of meningioma: more benefits to patients.","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"coi260045r19","unstructured":"Sundhedsdatastyrelsen. The Danish Healthcare Classification System. 2025. Accessed May 20, 2025. https:\/\/sundhedsdatastyrelsen.dk\/indberetning\/klassifikationer\/sks-klassifikationer"},{"key":"coi260045r34","unstructured":"Group TDN-O. Guidelines in Neuro-Oncology. Accessed March 1, 2026. https:\/\/dnog.dk\/retningslinjer"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2853217\/jamaoncology_korshj_2026_oi_260045_1792007357.2473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:00:45Z","timestamp":1792076445000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2853217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2026.2943","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}